Company record · updated August 5, 2026
Lucira Health, Inc.: 6 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs January 15, 2021 to February 1, 2021.
6observations
2source filings
6verified rows
2021-02-01most recent as-of date
Source rails for this company: S-1 charter round (6).
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2021-02-01 | Series C price per share | 5.3905 USD | — | VERIFIED | "Original Issue Price" defined for Series C | 000119312521023778 |
| 2021-02-01 | Series B price per share | 4.6616 USD | — | VERIFIED | "Original Issue Price" defined for Series B | 000119312521023778 |
| 2021-02-01 | Series A price per share | 5.1185 USD | — | VERIFIED | "Original Issue Price" defined for Series A | 000119312521023778 |
| 2021-01-15 | Series C price per share | 1.2506 USD | — | VERIFIED | "Original Issue Price" defined for Series C | 000119312521010174 |
| 2021-01-15 | Series B price per share | 1.0815 USD | — | VERIFIED | "Original Issue Price" defined for Series B | 000119312521010174 |
| 2021-01-15 | Series A price per share | 1.1875 USD | — | VERIFIED | "Original Issue Price" defined for Series A | 000119312521010174 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price. The capabilities page states the full limits.